Combination of immunotherapeutics shows promise in murine glioblastoma
Researchers at the Children's Hospital of Eastern Ontario (Ottawa, ON, Canada) have discovered that SMAC Mimetic compounds and immune checkpoint inhibitors work synergistically and could be utilized in clinical application against cancerous tumors.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.